278650 — HLB BioStep Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩139bn
- KR₩134bn
- KR₩58bn
Annual cashflow statement for HLB BioStep Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 8,589 | 10,308 | -2,870 | -54.2 | -9,693 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1,140 | 360 | 11,379 | -913 | -137 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -321 | -5,231 | -6,132 | 2,683 | -6,543 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 11,464 | 8,463 | 6,481 | 5,192 | -11,670 |
| Capital Expenditures | -4,536 | -17,492 | -6,059 | -4,006 | -8,927 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3,208 | -2,075 | -74,784 | 59,724 | 10,394 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7,744 | -19,568 | -80,843 | 55,718 | 1,467 |
| Financing Cash Flow Items | 5 | 83.5 | 4,224 | -85 | -25.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -877 | 9,212 | 83,064 | -6,985 | -12,427 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,837 | -1,882 | 8,716 | 53,926 | -22,625 |